Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GD007 for Moderate-Severe Intrauterine Adhesions
NCT07101484Phase 1Enrolling by invitation
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- May 2025
- Primary completion
- May 2026
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Exosome liquid dressing in Intrauterine Adhesions (IUA) (4 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Incidence of severe intolerability after intrauterine perfusion of iPS cell-derived exosome liquid dressing at 6 months. Started May 2025; status: enrolling by invitation.
02
Drugs
Exosome liquid dressing
03
Conditions
Intrauterine Adhesions (IUA)
Beyond the preview
Go deeper on NCT07101484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07101484.